{
  "Variants Include": [
    {
      "Gene": "DJ-1",
      "variants": [
        {
          "HGVS": "NM_001145746.1:c.497T>C",
          "cDNA Change": {
            "transcript": "NM_001145746.1",
            "ref": "T",
            "alt": "C",
            "position": "497"
          },
          "Protein Change": {
            "ref": "L",
            "alt": "P",
            "position": "166"
          },
          "Description in input context": "L166P point mutation"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005154"
  },
  "Experiment Method": [
    {
      "Assay Method": "Cell viability and mitochondrial function assays",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y and primary neurons",
        "Description": "Experiments were conducted using SH-SY5Y cells and primary neurons."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001145746.1:c.497T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "The L166P variant caused decreased cell viability (MTT assay) and reduced mitochondrial membrane potential (JC-1 assay) compared to wild-type DJ-1."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Three technical replicates were performed for each condition."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "siRNA targeting luciferase was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "siRNA targeting DJ-1 was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "One-way ANOVA followed by post-hoc analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Cell viability > 80% and mitochondrial membrane potential > 90% of control.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Cell viability < 60% and mitochondrial membrane potential < 60% of control.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}